ITMI20050477A1 - Cerotto transdermico - Google Patents

Cerotto transdermico

Info

Publication number
ITMI20050477A1
ITMI20050477A1 IT000477A ITMI20050477A ITMI20050477A1 IT MI20050477 A1 ITMI20050477 A1 IT MI20050477A1 IT 000477 A IT000477 A IT 000477A IT MI20050477 A ITMI20050477 A IT MI20050477A IT MI20050477 A1 ITMI20050477 A1 IT MI20050477A1
Authority
IT
Italy
Prior art keywords
transdermic
patch
nitroglycerin
administration
transdermal patch
Prior art date
Application number
IT000477A
Other languages
English (en)
Inventor
Sergio Comuzi
Paola Stefanelli
Original Assignee
Bouty S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bouty S P A filed Critical Bouty S P A
Priority to IT000477A priority Critical patent/ITMI20050477A1/it
Priority to MX2007011681A priority patent/MX2007011681A/es
Priority to DK06725214.8T priority patent/DK1865931T3/da
Priority to PL06725214T priority patent/PL1865931T3/pl
Priority to US11/886,705 priority patent/US9549902B2/en
Priority to BRPI0609451-1A priority patent/BRPI0609451A2/pt
Priority to AU2006226348A priority patent/AU2006226348A1/en
Priority to PCT/EP2006/060930 priority patent/WO2006100251A1/en
Priority to CA2602534A priority patent/CA2602534C/en
Priority to EP06725214A priority patent/EP1865931B1/en
Priority to AT06725214T priority patent/ATE524167T1/de
Priority to ES06725214T priority patent/ES2373401T3/es
Priority to RU2007139110/15A priority patent/RU2420269C2/ru
Priority to PT06725214T priority patent/PT1865931E/pt
Priority to JP2008502401A priority patent/JP2008534474A/ja
Publication of ITMI20050477A1 publication Critical patent/ITMI20050477A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IT000477A 2005-03-23 2005-03-23 Cerotto transdermico ITMI20050477A1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT000477A ITMI20050477A1 (it) 2005-03-23 2005-03-23 Cerotto transdermico
MX2007011681A MX2007011681A (es) 2005-03-23 2006-03-22 Parche transdermico.
DK06725214.8T DK1865931T3 (da) 2005-03-23 2006-03-22 Transdermal plaster
PL06725214T PL1865931T3 (pl) 2005-03-23 2006-03-22 Plaster przezskórny
US11/886,705 US9549902B2 (en) 2005-03-23 2006-03-22 Transdermal patch
BRPI0609451-1A BRPI0609451A2 (pt) 2005-03-23 2006-03-22 emplastro transdérmico
AU2006226348A AU2006226348A1 (en) 2005-03-23 2006-03-22 Transdermal patch
PCT/EP2006/060930 WO2006100251A1 (en) 2005-03-23 2006-03-22 Transdermal patch
CA2602534A CA2602534C (en) 2005-03-23 2006-03-22 Transdermal patch
EP06725214A EP1865931B1 (en) 2005-03-23 2006-03-22 Transdermal patch
AT06725214T ATE524167T1 (de) 2005-03-23 2006-03-22 Transdermales pflaster
ES06725214T ES2373401T3 (es) 2005-03-23 2006-03-22 Parche transdérmico.
RU2007139110/15A RU2420269C2 (ru) 2005-03-23 2006-03-22 Трансдермальный пластырь
PT06725214T PT1865931E (pt) 2005-03-23 2006-03-22 Emplastro transdérmico
JP2008502401A JP2008534474A (ja) 2005-03-23 2006-03-22 経皮パッチ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000477A ITMI20050477A1 (it) 2005-03-23 2005-03-23 Cerotto transdermico

Publications (1)

Publication Number Publication Date
ITMI20050477A1 true ITMI20050477A1 (it) 2006-09-24

Family

ID=35262212

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000477A ITMI20050477A1 (it) 2005-03-23 2005-03-23 Cerotto transdermico

Country Status (15)

Country Link
US (1) US9549902B2 (it)
EP (1) EP1865931B1 (it)
JP (1) JP2008534474A (it)
AT (1) ATE524167T1 (it)
AU (1) AU2006226348A1 (it)
BR (1) BRPI0609451A2 (it)
CA (1) CA2602534C (it)
DK (1) DK1865931T3 (it)
ES (1) ES2373401T3 (it)
IT (1) ITMI20050477A1 (it)
MX (1) MX2007011681A (it)
PL (1) PL1865931T3 (it)
PT (1) PT1865931E (it)
RU (1) RU2420269C2 (it)
WO (1) WO2006100251A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8846740B2 (en) 2011-01-04 2014-09-30 Biological Responsibility, Llc Biotherapeutics for the treatment of infectious diseases
US9044390B1 (en) 2014-04-17 2015-06-02 Gary J. Speier Pharmaceutical composition and method of manufacturing
US9186386B2 (en) 2014-04-17 2015-11-17 Gary J. Speier Pharmaceutical composition and method of manufacturing
JP6650730B2 (ja) 2015-10-22 2020-02-19 日東電工株式会社 超小型固定用テープおよびそれを含む物品
WO2017136617A1 (en) 2016-02-04 2017-08-10 Cinrx Pharma, Llc Deuterated domperidone compositions and methods for therapy of disorders
KR20240125702A (ko) 2017-06-30 2024-08-19 신돔 파마, 인크. 중수소화 돔페리돈 조성물, 방법, 및 제조
US12070440B2 (en) * 2022-06-27 2024-08-27 Permeatus, Inc. Topical formulations of nitroglycerin
CN117653610B (zh) * 2023-09-28 2024-07-05 海南卓科制药有限公司 一种硝酸甘油片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561608B1 (en) * 1985-11-04 1987-05-14 Paco Research Corp. Transdermal vasoactive delivery
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico

Also Published As

Publication number Publication date
RU2420269C2 (ru) 2011-06-10
JP2008534474A (ja) 2008-08-28
BRPI0609451A2 (pt) 2010-04-06
EP1865931B1 (en) 2011-09-14
ATE524167T1 (de) 2011-09-15
MX2007011681A (es) 2008-01-28
PL1865931T3 (pl) 2012-02-29
CA2602534A1 (en) 2006-09-28
AU2006226348A1 (en) 2006-09-28
WO2006100251A1 (en) 2006-09-28
RU2007139110A (ru) 2009-04-27
EP1865931A1 (en) 2007-12-19
US9549902B2 (en) 2017-01-24
PT1865931E (pt) 2012-01-05
ES2373401T3 (es) 2012-02-03
DK1865931T3 (da) 2011-12-05
CA2602534C (en) 2015-05-05
US20090028929A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
CY1117615T1 (el) Ενωσεις θειαζολης σουλφοναμιδης και οξαζολης
ITMI20050477A1 (it) Cerotto transdermico
CR10157A (es) Compuestos químicos
BRPI0809366A8 (pt) polipeptídeos interligados
EA201070786A1 (ru) Бензофуропиримидиноны
ECSP066883A (es) Derivados de heteroarilaminopirazol utiles para el tratamiento de la diabetes
FR2883179B1 (fr) Comprime enrobe
CL2012002944A1 (es) Compuestos derivados de amino-pirimidinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras.
CL2012002945A1 (es) Compuestos derivados de amino-piridazinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras.
DK2058020T3 (da) Indretning til indgivelse af lægemiddel
EA200802008A1 (ru) Фармацевтические композиции
BRPI0508894A (pt) meios para administração transdérmica de nicotina e uso
NO20075068L (no) Lipocalinprotein
ECSP055953A (es) Granisetron transdermico
NO20064555L (no) HIV-integraseinhibitorer.
DOP2005000025A (es) Compuestos de heteroaril- y fenilsulfamoilo sustituidos
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
EA200702529A1 (ru) Фунгицидная комбинация биологически активных веществ
AR054507A1 (es) Sistema transdermico de vareniclina
ME01459B (me) Postupak za doziranje medikamenata
ATE506340T1 (de) 12-aryl-prostaglandin-analoga
TW200621160A (en) Anti-termite agent
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
BRPI0515267A (pt) métodos de extração de polìmero com solvente único
NO20074623L (no) Fremgangsmate for peptidsyntese